Lymphoma Outcomes Hinge on Oncology, Not Viral Load In People With HIV - The American Journal of Managed Care
Lymphoma Outcomes Hinge on Oncology, Not Viral Load In People With HIV The American Journal of Managed Care
Non-Hodgkin Lymphoma News
Mantle Cell Lymphoma Guidelines Let Some Patients Skip Transplant - Cure Today
Mantle Cell Lymphoma Guidelines Let Some Patients Skip Transplant Cure Today
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial - Nature
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial Nature
Expanding the Role of Immunotherapy in Lymphoma - Targeted Oncology
Expanding the Role of Immunotherapy in Lymphoma Targeted Oncology
Maesteg teen whose cancer returned after remission has clinical trial hope - BBC
Maesteg teen whose cancer returned after remission has clinical trial hope BBC
Hodgkin vs. Non-Hodgkin Lymphoma: How To Tell the Difference - Health.com
Hodgkin vs. Non-Hodgkin Lymphoma: How To Tell the Difference Health.com
Beyond the Nodes: Atypical Presentations of Non-Hodgkin's Lymphoma Across Organs - The Cureus Journal of Medical Science
Beyond the Nodes: Atypical Presentations of Non-Hodgkin's Lymphoma Across Organs The Cureus Journal of Medical Science
Study reveals promising new therapy for non-Hodgkin lymphoma - Medical Xpress
Study reveals promising new therapy for non-Hodgkin lymphoma Medical Xpress
Targeting CAR-T cell exhaustion in non-Hodgkin lymphoma: mechanistic insights and emerging clinical strategies - Frontiers
Targeting CAR-T cell exhaustion in non-Hodgkin lymphoma: mechanistic insights and emerging clinical strategies Frontiers
National Poetry Month: "Non-Hodgkin’s Lymphoma" - The Rumpus
National Poetry Month: "Non-Hodgkin’s Lymphoma" The Rumpus
7 Signs of Non-Hodgkin Lymphoma You Shouldn’t Ignore - Hartford HealthCare
7 Signs of Non-Hodgkin Lymphoma You Shouldn’t Ignore Hartford HealthCare
Advances in lymphoma treatment: new therapies and clinical trials - Penn Medicine
Advances in lymphoma treatment: new therapies and clinical trials Penn Medicine
Report: Counties that spray the most glyphosate have higher non-Hodgkin lymphoma rates - Iowa Capital Dispatch
Report: Counties that spray the most glyphosate have higher non-Hodgkin lymphoma rates Iowa Capital Dispatch
New long-term analysis suggests follicular lymphoma can be cured - Fred Hutchinson Cancer Center
New long-term analysis suggests follicular lymphoma can be cured Fred Hutchinson Cancer Center
Dual-acting drug from AbbVie, Genmab scores in frontline lymphoma trial - BioPharma Dive
Dual-acting drug from AbbVie, Genmab scores in frontline lymphoma trial BioPharma Dive
Radioimmunotherapy of B-Cell Non-Hodgkin’s Lymphoma: From Clinical Trials to Clinical Practice - Journal of Nuclear Medicine
Radioimmunotherapy of B-Cell Non-Hodgkin’s Lymphoma: From Clinical Trials to Clinical Practice Journal of Nuclear Medicine
Mosunetuzumab With Response-Adapted Therapy in Previously Untreated NHL - The ASCO Post
Mosunetuzumab With Response-Adapted Therapy in Previously Untreated NHL The ASCO Post
Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma: a pooled analysis of four prospective cohorts - Nature
Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma: a pooled analysis of four prospective cohorts Nature
CD20-Positive B-Cell Non-Hodgkin Lymphoma Associated With Recurrent Acute Pancreatitis, Bilateral Renal Lesions, and Retroperitoneal Lymphadenopathy - Cureus
CD20-Positive B-Cell Non-Hodgkin Lymphoma Associated With Recurrent Acute Pancreatitis, Bilateral Renal Lesions, and Retroperitoneal Lymphadenopathy Cureus
Ureteral Involvement in Non-Hodgkin Lymphoma: A Rare Case Report With Diagnostic Challenges - Cureus
Ureteral Involvement in Non-Hodgkin Lymphoma: A Rare Case Report With Diagnostic Challenges Cureus
Sweet November Cancer Explained: Keanu Reeves, Charlize Theron and Sara’s Non-Hodgkin Lymphoma - Oncodaily
Sweet November Cancer Explained: Keanu Reeves, Charlize Theron and Sara’s Non-Hodgkin Lymphoma Oncodaily
Non-Hodgkin’s lymphoma presenting as a retroperitoneal mass in the emergency department: a case report - Frontiers
Non-Hodgkin’s lymphoma presenting as a retroperitoneal mass in the emergency department: a case report Frontiers
Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down - STAT
Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down STAT
Primary classical Hodgkin lymphoma of breast presenting as recurrent breast abscess in a non-lactating woman: a case report and literature review - Frontiers
Primary classical Hodgkin lymphoma of breast presenting as recurrent breast abscess in a non-lactating woman: a case report and literature review Frontiers
The Evolving Roles of MRD and Molecular Genotyping in Non-Hodgkin Lymphoma - CancerNetwork
The Evolving Roles of MRD and Molecular Genotyping in Non-Hodgkin Lymphoma CancerNetwork
Epigenetic priming with azacitidine-BEAM versus decitabine-BEAM conditioning for autologous transplantation in non-Hodgkin’s lymphoma - Nature
Epigenetic priming with azacitidine-BEAM versus decitabine-BEAM conditioning for autologous transplantation in non-Hodgkin’s lymphoma Nature
Rethinking Dual Targeting, Durability After CAR-T in Non-Hodgkin Lymphoma - CancerNetwork
Rethinking Dual Targeting, Durability After CAR-T in Non-Hodgkin Lymphoma CancerNetwork
Stanford scientists turn a cancer driver into a kill switch - Science Daily
Stanford scientists turn a cancer driver into a kill switch Science Daily
Dural Follicular Non-Hodgkin Lymphoma Mimicking a Chronic Subdural Hematoma: A Case Report and Literature Review - Cureus
Dural Follicular Non-Hodgkin Lymphoma Mimicking a Chronic Subdural Hematoma: A Case Report and Literature Review Cureus
Metachronous multiple primary cancers involving pulmonary non-Hodgkin lymphoma and bladder cancer: a case report - Frontiers
Metachronous multiple primary cancers involving pulmonary non-Hodgkin lymphoma and bladder cancer: a case report Frontiers
FDA Orphan Drug Status Awarded to EO2463 in Indolent Non-Hodgkin Lymphoma - Targeted Oncology
FDA Orphan Drug Status Awarded to EO2463 in Indolent Non-Hodgkin Lymphoma Targeted Oncology
Non-Hodgkin's Lymphoma Market Size to Hit USD 26.22 Billion by 2035 - Precedence Research
Non-Hodgkin's Lymphoma Market Size to Hit USD 26.22 Billion by 2035 Precedence Research
Editorial: New molecular targets for personalized treatment for low-grade non-hodgkin lymphoma - Frontiers
Editorial: New molecular targets for personalized treatment for low-grade non-hodgkin lymphoma Frontiers
Current treatment algorithm: diffuse large B cell lymphoma - Blood Cancer Journal - Nature
Current treatment algorithm: diffuse large B cell lymphoma - Blood Cancer Journal Nature
Low-grade B-cell non-Hodgkin lymphoma in the sternocleidomastoid muscle: a case report and review of literature - Frontiers
Low-grade B-cell non-Hodgkin lymphoma in the sternocleidomastoid muscle: a case report and review of literature Frontiers
A Rare Case of Motor Neuropathy Secondary to Non-Hodgkin Lymphoma - Cureus
A Rare Case of Motor Neuropathy Secondary to Non-Hodgkin Lymphoma Cureus
U.S. Supreme Court Blocks Roundup Lawsuits Over Non-Hodgkin’s Lymphoma Warnings - AboutLawsuits.com
U.S. Supreme Court Blocks Roundup Lawsuits Over Non-Hodgkin’s Lymphoma Warnings AboutLawsuits.com
Miami F Marcus Allen has non-Hodgkin lymphoma, out for season - ESPN
Miami F Marcus Allen has non-Hodgkin lymphoma, out for season ESPN
Hepatitis virus-associated B cell non-Hodgkin’s lymphoma involves dysregulated epigenetic and RNA-mediated regulatory gene expression and altered snoRNA transcription - Nature
Hepatitis virus-associated B cell non-Hodgkin’s lymphoma involves dysregulated epigenetic and RNA-mediated regulatory gene expression and altered snoRNA transcription Nature
In Vivo CD19/CD20 CAR T-Cell Therapy Is Safe, Yields 100% ORR at Phase 1, Dose Level 2 in R/R Non-Hodgkin Lymphomas - OncLive
In Vivo CD19/CD20 CAR T-Cell Therapy Is Safe, Yields 100% ORR at Phase 1, Dose Level 2 in R/R Non-Hodgkin Lymphomas OncLive